Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice. | JHEP Rep | 2024 | 38074508 | PubTator, text mining | PubMed |
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis. | Eur J Pharmacol | 2024 | 38056616 | PubTator, text mining | PubMed |
| FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1. | Biomed Pharmacother | 2024 | 38048735 | PubTator, text mining | PubMed |
| Developmental impacts and toxicological hallmarks of silver nanoparticles across diverse biological models. | Environ Sci Ecotechnol | 2024 | 38046179 | PubTator, text mining | PubMed |
| VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner. | Oncogene | 2024 | 37950040 | PubTator, text mining | PubMed |
| The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer. | Cell Oncol (Dordr) | 2024 | 37945798 | PubTator, text mining | PubMed |
| ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. | Mol Cancer Res | 2024 | 37930255 | PubTator, text mining | PubMed |
| FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination. | Cell Oncol (Dordr) | 2024 | 37782406 | PubTator, text mining | PubMed |
| A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis. | Hepatology | 2024 | 37732990 | PubTator, text mining | PubMed |
| Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings. | EXCLI J | 2023 | 38234969 | PubTator, text mining | PubMed |
| The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis. | Int J Mol Sci | 2023 | 38203309 | PubTator, text mining | PubMed |
| Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 38169604 | PubTator, text mining | PubMed |
| Targeted therapy for multiple gene mutations in multiple metastases of advanced gastric cancer: a case report. | Front Oncol | 2023 | 38162498 | PubTator, text mining | PubMed |
| Spheroid size influences cellular senescence and angiogenic potential of mesenchymal stromal cell-derived soluble factors and extracellular vesicles. | Front Bioeng Biotechnol | 2023 | 38162179 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link. | J Clin Transl Hepatol | 2023 | 38161503 | PubTator, text mining | PubMed |
| MASLD treatment-a shift in the paradigm is imminent. | Front Med (Lausanne) | 2023 | 38146424 | PubTator, text mining | PubMed |
| The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review. | Int J Mol Sci | 2023 | 38139126 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation. | Life (Basel) | 2023 | 38137868 | PubTator, text mining | PubMed |
| Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD. | Biomedicines | 2023 | 38137523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=20